Mesenchymal stem cells (MSC) exhibit a high self‐renewal capacity, multilineage
differentiation potential and immunomodulatory properties. This set of exceptional features …

Over the past 2 decades, mesenchymal stem cells (MSCs) have attracted a lot of interest as
a unique therapeutic approach for a variety of diseases. MSCs are capable of self-renewal …

The human umbilical cord (UC) and placenta are non-invasive, primitive and abundant
sources of mesenchymal stromal cells (MSCs) that have increasingly gained attention …

Mesenchymal stromal cells (MSCs) are widely used in the clinic because they involve fewer
ethical issues and safety concerns compared to other stem cells such as embryonic stem …

Mesenchymal stem cell (MSC) research progressively moves towards clinical phases.
Accordingly, a wide range of different procedures were presented in the literature for MSC …

The multipotent and immunosuppressive capacities of mesenchymal stem cells (MSCs)
attract several scientists worldwide towards translational research focusing on treatment of …

Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to
collect lifesaving Wharton's jelly derived mesenchymal stem cells (WJ‐MSC). Evidences that …

Diabetes mellitus type 1 and type 2 have become a global epidemic with dramatically
increasing incidences. Poorly controlled diabetes is associated with severe life-threatening …

Mesenchymal stem cells (MSC) comprise a heterogeneous population of rapidly
proliferating cells that can be isolated from adult (eg, bone marrow, adipose tissue) as well …

Mesenchymal stem/stromal cells (MSCs) are currently one of the most extensively
researched fields due to their promising opportunity for use in regenerative medicine. There …